DuPont C-8 Trial Over Cancer from Tephlon Chemical Leak Results in $1.6M Award

In the first trial for a DuPont C-8 water contamination lawsuits, a federal jury awarded $1.6 million to a woman who alleged that she developed cancer after the chemical used to manufacturer Tephlon leaked from a West Virginia plant.

The lawsuit was filed by Carla Bartlett, following chemical leaks from a DuPont plant before 2004, which entered local waterways and allegedly caused her to suffer kidney cancer.

Barlett is one of about 3,500 individuals residents around DuPont’s Washington Works Plant in Parkersburg, West Virginia who are pursuing a lawsuit against DuPont over C-8 exposure. Plaintiffs allege that they suffered various injuries due to the release of perfluorooctanoic acid (PFOA), also known as C-8 or C8, which is a chemical used to manufacture products like Teflon and Gore-Tex.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Plaintiffs claim that DuPont knew for years that C8 from the plant posed serious health problems for area residents, including a risk of cancer, birth defects and other complications. The company also allegedly did little to prevent numerous spills and releases into the environment, the lawsuits claim.

Since November 2013, all complaints filed throughout the federal court system have been centralized for pretrial proceedings before U.S. District Judge Edmund A. Sargus in the Southern District of West Virginia.

Bartlett’s claim was the first to go to trial, with a second trial scheduled to begin in November. While the outcomes of the cases are not binding on other claims in the litigation, they are being closely watched by lawyers involved in the lawsuits, as they may influence eventual DuPont C-8 exposure settlement negotiations.

Following a three-week trial, the jury agreed that Bartlett’s cancer was caused by exposure to C-8, and awarded compensatory damages of $1.6 million. The jury declined to levy punitive damages against DuPont’s Chemours Co. subsidiary, after finding that the manufacturer had not acted maliciously in the chemical releases.

DuPont C-8 Health Problems

DuPont C-8 is a toxic, cancer-causing agent that stays in the environment indefinitely; never breaking down, according to allegations in the lawsuits filed by area residents.

Studies have linked C-8 exposure to kidney disease, thyroid disease, ulcerative colitis, testicular cancer, pregnancy-induced hypertension, and increases in cholesterol.

Lawsuits filed by residents allege that they were affected by the contamination of their water supply. The lawsuits claim the company knew C-8 was toxic since at least 1961 but failed to take adequate steps to prevent water contamination or to warn workers or nearby residents of the health risks.

The lawsuits claim the company went as far as covering up the side effects of C-8 and lying to residents and health officials.

In the wake of a 2005 class action lawsuit brought by residents against Du Pont, a panel of independent epidemiologists was assigned to look at the dangers of C-8. In a study released in July, they confirmed many of the ailments linked to exposure. The study looked at 70,000 residents who were exposed to the chemical via their drinking water.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.